Quote:
Originally Posted by Harry Z
Please don't shoot the messenger.... this was posted September 22.....Harry
NEW YORK — The Food and Drug Administration says it confirmed three new cases of a potentially lethal brain inflammation linked to the multiple sclerosis drug Tysabri.
There have been 13 reported cases of progressive multifocal leukoencephalopathy, or PML, since mid-2006. The reports are the first confirmed new cases since June. While the disease is rare, the FDA says the risk appears to increase as patients remain on Tysabri.
Tysabri is marketed by Biogen Idec Inc. and Elan Corp. PLC, for multiple sclerosis and Crohn's disease. All the PML cases are linked to its use in multiple sclerosis.
The drug was approved in November 2004 and pulled from the market the next year due to PML reports. It was reintroduced in July 2006, and Biogen said it is used by 43,000 patients.
|
Harry, I think the numbers are getting kinda confusing.
When Biogen quit announcing the numbers, there were 11 cases that we knew about already, plus the 3 from the trials (for a total of 14) ... but that included one case from
July/09.
http://pietynorwit.com/Tytable.htm
These articles say there are 3 new cases since
JUNE, so that must exclude the one we already knew about from July. That would mean 11 - 1 = 10, then the cases from July - Sept 8 = 10 + 3 (new ones) = 13 (+ the 3 from the trials) = 16 all up now.
Cherie
__________________
I am not a Neurologist, Physician, Nurse, or Hairdresser ... but I have learned that it is not such a great idea to give oneself a haircut after three margaritas
.